Comparing the Effectiveness of Betamethasone Gel with Lidocaine Gel Application on Endotracheal Tube in Preventing Post Operating Sore Throat
DOI:
https://doi.org/10.53350/pjmhs20221611261Abstract
Objective: To compare the effectiveness of betamethasone gel and lidocaine gel application in reduction of post-operative sore throat.
Study Design: Randomized controlled trial
Place and Duration: Study was conducted at anesthesia department of Dow University of Health Sciences, Karachi with duration from May 2022 to October 2022.
Methodology: A total of 54 patients were enrolled and divided into two groups Betamethasone and Lidocaine (Lignocaine) by lottery method. In one group betamethasone gel 0.05% was applied over endotracheal tube (ETT) and in other group lignocaine gel 4% was applied over the ETTT. SPSS version 23 was used for data analysis. Mean ± SD and frequency (percentage) were calculated for numerical and categorical data respectively.
Results: Majority of the patients in betamethasone group, 15 (55.6%) patients, had not developed sore throat whereas mild and moderate sore throat was most common in lidocaine group. Further, 5 (18.5%) patients in lidocaine group and only 2 (7.4%) patients in betamethasone group was severe sore throat. (p=0.015).
Practical implication: Sore throat is a common post-operative complication having potential to lead poor surgical results. This study will help the clinicians/anesthesiologists to overcome the problem and reduce the incidence of sore throat in routine practice.
Conclusion: Application of betamethasone gel over endotracheal tube just before insertion is associated with reduced risk of sore throat as compare to lignocaine gel.
Keywords: Lidocaine gel, Betamethasone gel, Post-operative sore throat, Laryngoscopy, Endotracheal tube.
Downloads
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.